Positron emission tomography (PET) scanning in breast cancer.
- 1 July 1997
- journal article
- review article
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 70 (835) , 668-670
- https://doi.org/10.1259/bjr.70.835.9245877
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Qualitative [18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicabilityEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose.Journal of Clinical Oncology, 1996
- Omission of axillary lymph node dissection in early-stage breast cancer: effect on treatment outcome.Radiology, 1995
- PET FDG studies in oncologyNuclear Medicine and Biology, 1994
- Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.Journal of Clinical Oncology, 1993
- Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancerCancer, 1993
- Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET.Radiology, 1993
- The Application of Positron Emission Tomographie Imaging With Fluorodeoxyglucose to the Evaluation of Breast DiseaseAnnals of Surgery, 1992
- Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology, 1991